Pharmaceutical Market Size - Global Industry, Share, Analysis, Trends and Forecast 2023 - 2032
CHAPTER 1. Industry Overview of Pharmaceutical Market
1.1. Definition and Scope
1.1.1. Definition of Pharmaceutical
1.1.2. Market Segmentation
1.1.3. Years Considered for the Study
1.1.4. Assumptions and Acronyms Used
1.1.4.1. Market Assumptions and Market Forecast
1.1.4.2. Acronyms Used in Global Pharmaceutical Market
1.2. Summary
1.2.1. Executive Summary
1.2.2. Pharmaceutical Market By Therapeutic Category
1.2.3. Pharmaceutical Market By Drug Type
1.2.4. Pharmaceutical Market By Prescription Type
1.2.5. Pharmaceutical Market By Region
CHAPTER 2. Research Approach
2.1. Methodology
2.1.1. Research Programs
2.1.2. Market Size Estimation
2.1.3. Market Breakdown and Data Triangulation
2.2. Data Source
2.2.1. Secondary Source
2.2.2. Primary Source
CHAPTER 3. Market Dynamics And Competition Analysis
3.1. Market Drivers
3.1.1. Driver 1
3.1.2. Driver 2
3.2. Restraints and Challenges
3.2.1. Restraint 1
3.2.2. Restraint 2
3.3. Growth Opportunities
3.3.1. Opportunity 1
3.3.2. Opportunity 2
3.4. Porter’s Five Forces Analysis
3.4.1. Bargaining Power of Suppliers
3.4.2. Bargaining Power of Buyers
3.4.3. Threat of Substitute
3.4.4. Threat of New Entrants
3.4.5. Degree of Competition
3.5. Market Concentration Ratio and Market Maturity Analysis of Pharmaceutical Market
3.5.1. Go To Market Strategy
3.5.1.1. Introduction
3.5.1.2. Growth
3.5.1.3. Maturity
3.5.1.4. Saturation
3.5.1.5. Possible Development
3.6. Technological Roadmap for Pharmaceutical Market
3.7. Value Chain Analysis
3.7.1. List of Key Manufacturers
3.7.2. List of Customers
3.7.3. Level of Integration
3.8. Price Trend of Key Raw Material
3.8.1. Raw Material Suppliers
3.8.2. Proportion of Manufacturing Cost Structure
3.8.2.1. Raw Material
3.8.2.2. Labor Cost
3.8.2.3. Manufacturing Expense
3.9. Regulatory Compliance
3.10. Competitive Landscape, 2022
3.10.1. Player Positioning Analysis
3.10.2. Key Strategies Adopted By Leading Players
CHAPTER 4. Manufacturing Plant Analysis
4.1. Manufacturing Plant Location and Establish Date of Major Manufacturers in 2022
4.2. R&D Status of Major Manufacturers in 2022
CHAPTER 5. Pharmaceutical Market By Therapeutic Category
5.1. Introduction
5.2. Pharmaceutical Revenue By Therapeutic Category
5.2.1. Pharmaceutical Revenue (USD Trillion) and Forecast, By Therapeutic Category, 2020-2032
5.2.2. Anti-Infectives
5.2.2.1. Anti-Infectives Market Revenue (USD Trillion) and Growth Rate (%), 2020-2032
5.2.3. Gastrointestinal
5.2.3.1. Gastrointestinal Market Revenue (USD Trillion) and Growth Rate (%), 2020-2032
5.2.4. Cardiovascular
5.2.4.1. Cardiovascular Market Revenue (USD Trillion) and Growth Rate (%), 2020-2032
5.2.5. Respiratory
5.2.5.1. Respiratory Market Revenue (USD Trillion) and Growth Rate (%), 2020-2032
5.2.6. Anti Diabetic
5.2.6.1. Anti Diabetic Market Revenue (USD Trillion) and Growth Rate (%), 2020-2032
5.2.7. Dermatologicals
5.2.7.1. Dermatologicals Market Revenue (USD Trillion) and Growth Rate (%), 2020-2032
5.2.8. Nervous System
5.2.8.1. Nervous System Market Revenue (USD Trillion) and Growth Rate (%), 2020-2032
5.2.9. Musculo-Skeletal System
5.2.9.1. Musculo-Skeletal System Market Revenue (USD Trillion) and Growth Rate (%), 2020-2032
5.2.10. Others
5.2.10.1. Others Market Revenue (USD Trillion) and Growth Rate (%), 2020-2032
CHAPTER 6. Pharmaceutical Market By Drug Type
6.1. Introduction
6.2. Pharmaceutical Revenue By Drug Type
6.2.1. Pharmaceutical Revenue (USD Trillion) and Forecast, By Drug Type, 2020-2032
6.2.2. Generic
6.2.2.1. Generic Market Revenue (USD Trillion) and Growth Rate (%), 2020-2032
6.2.3. Branded
6.2.3.1. Branded Market Revenue (USD Trillion) and Growth Rate (%), 2020-2032
CHAPTER 7. Pharmaceutical Market By Prescription Type
7.1. Introduction
7.2. Pharmaceutical Revenue By Prescription Type
7.2.1. Pharmaceutical Revenue (USD Trillion) and Forecast, By Prescription Type, 2020-2032
7.2.2. OTC Drugs
7.2.2.1. OTC Drugs Market Revenue (USD Trillion) and Growth Rate (%), 2020-2032
7.2.3. Prescription Drugs
7.2.3.1. Prescription Drugs Market Revenue (USD Trillion) and Growth Rate (%), 2020-2032
CHAPTER 8. North America Pharmaceutical Market By Country
8.1. North America Pharmaceutical Market Overview
8.2. U.S.
8.2.1. U.S. Pharmaceutical Revenue (USD Trillion) and Forecast By Therapeutic Category, 2020-2032
8.2.2. U.S. Pharmaceutical Revenue (USD Trillion) and Forecast By Drug Type, 2020-2032
8.2.3. U.S. Pharmaceutical Revenue (USD Trillion) and Forecast By Prescription Type, 2020-2032
8.3. Canada
8.3.1. Canada Pharmaceutical Revenue (USD Trillion) and Forecast By Therapeutic Category, 2020-2032
8.3.2. Canada Pharmaceutical Revenue (USD Trillion) and Forecast By Drug Type, 2020-2032
8.3.3. Canada Pharmaceutical Revenue (USD Trillion) and Forecast By Prescription Type, 2020-2032
8.4. North America PEST Analysis
CHAPTER 9. Europe Pharmaceutical Market By Country
9.1. Europe Pharmaceutical Market Overview
9.2. U.K.
9.2.1. U.K. Pharmaceutical Revenue (USD Trillion) and Forecast By Therapeutic Category, 2020-2032
9.2.2. U.K. Pharmaceutical Revenue (USD Trillion) and Forecast By Drug Type, 2020-2032
9.2.3. U.K. Pharmaceutical Revenue (USD Trillion) and Forecast By Prescription Type, 2020-2032
9.3. Germany
9.3.1. Germany Pharmaceutical Revenue (USD Trillion) and Forecast By Therapeutic Category, 2020-2032
9.3.2. Germany Pharmaceutical Revenue (USD Trillion) and Forecast By Drug Type, 2020-2032
9.3.3. Germany Pharmaceutical Revenue (USD Trillion) and Forecast By Prescription Type, 2020-2032
9.4. France
9.4.1. France Pharmaceutical Revenue (USD Trillion) and Forecast By Therapeutic Category, 2020-2032
9.4.2. France Pharmaceutical Revenue (USD Trillion) and Forecast By Drug Type, 2020-2032
9.4.3. France Pharmaceutical Revenue (USD Trillion) and Forecast By Prescription Type, 2020-2032
9.5. Spain
9.5.1. Spain Pharmaceutical Revenue (USD Trillion) and Forecast By Therapeutic Category, 2020-2032
9.5.2. Spain Pharmaceutical Revenue (USD Trillion) and Forecast By Drug Type, 2020-2032
9.5.3. Spain Pharmaceutical Revenue (USD Trillion) and Forecast By Prescription Type, 2020-2032
9.6. Rest of Europe
9.6.1. Rest of Europe Pharmaceutical Revenue (USD Trillion) and Forecast By Therapeutic Category, 2020-2032
9.6.2. Rest of Europe Pharmaceutical Revenue (USD Trillion) and Forecast By Drug Type, 2020-2032
9.6.3. Rest of Europe Pharmaceutical Revenue (USD Trillion) and Forecast By Prescription Type, 2020-2032
9.7. Europe PEST Analysis
CHAPTER 10. Asia Pacific Pharmaceutical Market By Country
10.1. Asia Pacific Pharmaceutical Market Overview
10.2. China
10.2.1. China Pharmaceutical Revenue (USD Trillion) and Forecast By Therapeutic Category, 2020-2032
10.2.2. China Pharmaceutical Revenue (USD Trillion) and Forecast By Drug Type, 2020-2032
10.2.3. China Pharmaceutical Revenue (USD Trillion) and Forecast By Prescription Type, 2020-2032
10.3. Japan
10.3.1. Japan Pharmaceutical Revenue (USD Trillion) and Forecast By Therapeutic Category, 2020-2032
10.3.2. Japan Pharmaceutical Revenue (USD Trillion) and Forecast By Drug Type, 2020-2032
10.3.3. Japan Pharmaceutical Revenue (USD Trillion) and Forecast By Prescription Type, 2020-2032
10.4. India
10.4.1. India Pharmaceutical Revenue (USD Trillion) and Forecast By Therapeutic Category, 2020-2032
10.4.2. India Pharmaceutical Revenue (USD Trillion) and Forecast By Drug Type, 2020-2032
10.4.3. India Pharmaceutical Revenue (USD Trillion) and Forecast By Prescription Type, 2020-2032
10.5. Australia
10.5.1. Australia Pharmaceutical Revenue (USD Trillion) and Forecast By Therapeutic Category, 2020-2032
10.5.2. Australia Pharmaceutical Revenue (USD Trillion) and Forecast By Drug Type, 2020-2032
10.5.3. Australia Pharmaceutical Revenue (USD Trillion) and Forecast By Prescription Type, 2020-2032
10.6. South Korea
10.6.1. South Korea Pharmaceutical Revenue (USD Trillion) and Forecast By Therapeutic Category, 2020-2032
10.6.2. South Korea Pharmaceutical Revenue (USD Trillion) and Forecast By Drug Type, 2020-2032
10.6.3. South Korea Pharmaceutical Revenue (USD Trillion) and Forecast By Prescription Type, 2020-2032
10.7. Rest of Asia-Pacific
10.7.1. Rest of Asia-Pacific Pharmaceutical Revenue (USD Trillion) and Forecast By Therapeutic Category, 2020-2032
10.7.2. Rest of Asia-Pacific Pharmaceutical Revenue (USD Trillion) and Forecast By Drug Type, 2020-2032
10.7.3. Rest of Asia-Pacific Pharmaceutical Revenue (USD Trillion) and Forecast By Prescription Type, 2020-2032
10.8. Asia Pacific PEST Analysis
CHAPTER 11. Latin America Pharmaceutical Market By Country
11.1. Latin America Pharmaceutical Market Overview
11.2. Brazil
11.2.1. Brazil Pharmaceutical Revenue (USD Trillion) and Forecast By Therapeutic Category, 2020-2032
11.2.2. Brazil Pharmaceutical Revenue (USD Trillion) and Forecast By Drug Type, 2020-2032
11.2.3. Brazil Pharmaceutical Revenue (USD Trillion) and Forecast By Prescription Type, 2020-2032
11.3. Mexico
11.3.1. Mexico Pharmaceutical Revenue (USD Trillion) and Forecast By Therapeutic Category, 2020-2032
11.3.2. Mexico Pharmaceutical Revenue (USD Trillion) and Forecast By Drug Type, 2020-2032
11.3.3. Mexico Pharmaceutical Revenue (USD Trillion) and Forecast By Prescription Type, 2020-2032
11.4. Rest of Latin America
11.4.1. Rest of Latin America Pharmaceutical Revenue (USD Trillion) and Forecast By Therapeutic Category, 2020-2032
11.4.2. Rest of Latin America Pharmaceutical Revenue (USD Trillion) and Forecast By Drug Type, 2020-2032
11.4.3. Rest of Latin America Pharmaceutical Revenue (USD Trillion) and Forecast By Prescription Type, 2020-2032
11.5. Latin America PEST Analysis
CHAPTER 12. Middle East & Africa Pharmaceutical Market By Country
12.1. Middle East & Africa Pharmaceutical Market Overview
12.2. GCC
12.2.1. GCC Pharmaceutical Revenue (USD Trillion) and Forecast By Therapeutic Category, 2020-2032
12.2.2. GCC Pharmaceutical Revenue (USD Trillion) and Forecast By Drug Type, 2020-2032
12.2.3. GCC Pharmaceutical Revenue (USD Trillion) and Forecast By Prescription Type, 2020-2032
12.3. South Africa
12.3.1. South Africa Pharmaceutical Revenue (USD Trillion) and Forecast By Therapeutic Category, 2020-2032
12.3.2. South Africa Pharmaceutical Revenue (USD Trillion) and Forecast By Drug Type, 2020-2032
12.3.3. South Africa Pharmaceutical Revenue (USD Trillion) and Forecast By Prescription Type, 2020-2032
12.4. Rest of Middle East & Africa
12.4.1. Rest of Middle East & Africa Pharmaceutical Revenue (USD Trillion) and Forecast By Therapeutic Category, 2020-2032
12.4.2. Rest of Middle East & Africa Pharmaceutical Revenue (USD Trillion) and Forecast By Drug Type, 2020-2032
12.4.3. Rest of Middle East & Africa Pharmaceutical Revenue (USD Trillion) and Forecast By Prescription Type, 2020-2032
12.5. Middle East & Africa PEST Analysis
CHAPTER 13. Player Analysis Of Pharmaceutical Market
13.1. Pharmaceutical Market Company Share Analysis
13.2. Competition Matrix
13.2.1. Competitive Benchmarking Of Key Players By Price, Presence, Market Share, And R&D Investment
13.2.2. New Product Launches and Product Enhancements
13.2.3. Mergers And Acquisition In Global Pharmaceutical Market
13.2.4. Partnership, Joint Ventures and Strategic Alliances/ Sales Agreements
CHAPTER 14. Company Profile
14.1. Takeda Pharmaceutical Company Limited
14.1.1. Company Snapshot
14.1.2. Business Overview
14.1.3. Financial Overview
14.1.3.1. Revenue (USD Trillion), 2022
14.1.3.2. Takeda Pharmaceutical Company Limited 2022 Pharmaceutical Business Regional Distribution
14.1.4. Product /Service and Specification
14.1.5. Recent Developments & Business Strategy
14.2. Pfizer Inc.
14.3. Astellas Pharma Inc.
14.4. Bayer AG
14.5. Merck & Co. Inc.
14.6. Eli Lilly and Company
14.7. GlaxoSmithKline PLC
14.8. Sanofi SA
14.9. Novartis International AG
14.10. Johnson and Johnson
14.11. Catalent Inc.
14.12. Aspen Holdings
Frequently Asked Questions
How big is the pharmaceutical market?
The market size of pharmaceutical was USD 1.5 Trillion in 2022.
What is the CAGR of the global pharmaceutical market from 2023 to 2032?
The CAGR of pharmaceutical is 6.4% during the analysis period of 2023 to 2032.
Which are the key players in the pharmaceutical market?
The key players operating in the global market are including Takeda Pharmaceutical Company Limited, Pfizer Inc., Astellas Pharma Inc., Bayer AG, Merck & Co. Inc., Eli Lilly and Company, GlaxoSmithKline PLC, Sanofi SA, Novartis International AG, Johnson and Johnson, Catalent Inc., and Aspen Holdings.
Which region dominated the global pharmaceutical market share?
North America held the dominating position in pharmaceutical industry during the analysis period of 2023 to 2032.
Which region registered fastest CAGR from 2023 to 2032?
Asia-Pacific region exhibited fastest growing CAGR for market of pharmaceutical during the analysis period of 2023 to 2032.
What are the current trends and dynamics in the global pharmaceutical industry?
The current trends and dynamics in the pharmaceutical industry include aging global population and increasing prevalence of chronic diseases, advances in medical technology and research, and rising healthcare awareness and expenditure.
Which drug type held the maximum share in 2022?
The generic drug type held the maximum share of the pharmaceutical industry.
Select Licence Type
Connect with our sales team
Why Acumen Research And Consulting
100%
Customer Satisfaction
24x7
Availability - we are always there when you need us
200+
Fortune 50 Companies trust Acumen Research and Consulting
80%
of our reports are exclusive and first in the industry
100%
more data and analysis
1000+
reports published till date
